SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
The COVID‐19 pandemic represents an unparalleled global public health crisis. Despite
concerted research endeavours, the repertoire of effective treatment options remains limited …
concerted research endeavours, the repertoire of effective treatment options remains limited …
Microfluidic immunoassays for point-of-care testing of SARS-CoV-2 antigens and antibodies
C Li, W Zhou, AG Ruiz, Y Mohammadi, Q Li… - TrAC Trends in …, 2024 - Elsevier
The point-of-care testing (POCT) of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) antigens and antibodies is of great significance in screening the infection and …
CoV-2) antigens and antibodies is of great significance in screening the infection and …
Automatic ultrasensitive lateral flow immunoassay based on a color-enhanced signal amplification strategy
H Jie, Y Wang, M Zhao, X Wang, Z Wang… - Biosensors and …, 2024 - Elsevier
Lateral flow immunoassays (LFIAs) are an essential and widely used point-of-care test for
medical diagnoses. However, commercial LFIAs still have low sensitivity and specificity …
medical diagnoses. However, commercial LFIAs still have low sensitivity and specificity …
Using the intrinsic fluorescence of DNA to characterize aptamer binding
The reliable, readily accessible and label-free measurement of aptamer binding remains a
challenge in the field. Recent reports have shown large changes in the intrinsic fluorescence …
challenge in the field. Recent reports have shown large changes in the intrinsic fluorescence …
Anti-SARS-CoV-2 antibody status at the time of hospital admission and the prognosis of patients with COVID-19: a prospective observational study
J Jurenka, A Nagyová, M Dababseh, P Mihalov… - Infectious Disease …, 2022 - mdpi.com
The association between COVID-19 severity and antibody response has not been clearly
determined. We aimed to assess the effects of antibody response to SARS-CoV-2 S protein …
determined. We aimed to assess the effects of antibody response to SARS-CoV-2 S protein …
Exploring Simple Particle-Based Signal Amplification Strategies in a Heterogeneous Sandwich Immunoassay with Optical Detection
Heterogeneous sandwich immunoassays are widely used for biomarker detection in
bioanalysis and medical diagnostics. The high analyte sensitivity of the current “gold …
bioanalysis and medical diagnostics. The high analyte sensitivity of the current “gold …
[HTML][HTML] Antibody drugs targeting SARS-CoV-2: Time for a rethink?
L Liang, B Wang, Q Zhang, S Zhang, S Zhang - Biomedicine & …, 2024 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) heavily burdens human health. Multiple …
respiratory syndrome coronavirus 2 (SARS-CoV-2) heavily burdens human health. Multiple …
Biosensors-A Miraculous Detecting Tool in Combating the War against COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly known as
COVID-19, created rack and ruin and erupted as a global epidemic. Nearly 482.3 million …
COVID-19, created rack and ruin and erupted as a global epidemic. Nearly 482.3 million …
Imaging Progression Under Low Respiratory Viral Load of SARS-CoV-2 Omicron Variant Infection: A Retrospective Study in China
Q Li, Y Wang, H Liu, H Peng, J Xiang… - Infection and Drug …, 2023 - Taylor & Francis
Purpose To investigate the computed tomography (CT) findings of SARs-CoV-2 Omicron
variant in relation to respiratory viral loads determined by cycle threshold values in reverse …
variant in relation to respiratory viral loads determined by cycle threshold values in reverse …
Exploring the vaccine-induced immunity against severe acute respiratory syndrome coronavirus 2 in healthcare workers
We aimed to analyze the kinetics of T-cell-mediated and B-cell-mediated humoral immune
responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before …
responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) before …